Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The therapeutic and preventive activities of retinoids in cancer are due to their ability to modulate the growth, differentiation, and survival or apoptosis of cancer cells. Here we show that in NB4 acute promyelocytic leukemia cells, retinoids selective for retinoic-acid receptor-alpha induced an autoregulatory circuitry of survival programs followed by expression of the membrane-bound tumor-selective death ligand, TRAIL (tumor necrosis factor-related apoptosis-inducing ligand, also called Apo-2L). In a paracrine mode of action, TRAIL killed NB4 as well as heterologous and retinoic-acid-resistant cells. In the leukemic blasts of freshly diagnosed acute promyelocytic leukemia patients, retinoic-acid-induced expression of TRAIL most likely caused blast apoptosis. Thus, induction of TRAIL-mediated death signaling appears to contribute to the therapeutic value of retinoids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
International Agency for Research on Cancer
National Cancer Institute (2020) · Definitions · doi:10.32388/pfg7jq · Cited by 9,435
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711
IAP family proteins---suppressors of apoptosis
Deveraux, Q. L., & Reed, J. C. (1999) · Genes & Development · doi:10.1101/gad.13.3.239 · Cited by 2,551
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497
Safety and antitumor activity of recombinant soluble Apo2 ligand
Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6926 · Cited by 2,213
The Receptor for the Cytotoxic Ligand TRAIL
Pan, G., O'Rourke, K., Chinnaiyan, A. M., Gentz, R., Ebner, R., Ni, J., & Dixit, V. M. (1997) · Science · doi:10.1126/science.276.5309.111 · Cited by 1,767
Programmed Cell Death and the Control of Cell Survival: Lessons from the Nervous System
Raff, M. C., Barres, B. A., Burne, J. F., Coles, H. S., Ishizaki, Y., & Jacobson, M. D. (1993) · Science · doi:10.1126/science.8235590 · Cited by 1,460
Apoptosis control by death and decoy receptors
Ashkenazi, A., & Dixit, V. M. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80034-9 · Cited by 1,288
The retinoids—Biology, chemistry and medicine
(1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80793-5 · Cited by 1,178
All-trans-Retinoic Acid in Acute Promyelocytic Leukemia
Tallman, M. S., Andersen, J. W., Schiffer, C. A., Appelbaum, F. R., Feusner, J. H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C. D., Rowe, J. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371501 · Cited by 1,073
The Retinoids-Biology, Chemistry and Medicine
Wolf, G. (1994) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/60.5.796a · Cited by 998
Nonsteroid nuclear receptors: What Are genetic studies telling us about their role in real life?
Kastner, P., Mark, M., & Chambon, P. (1995) · Cell · doi:10.1016/0092-8674(95)90202-3 · Cited by 995
Apo2L/TRAIL-Dependent Recruitment of Endogenous FADD and Caspase-8 to Death Receptors 4 and 5
Kischkel, F. C., Lawrence, D. A., Chuntharapai, A., Schow, P., Kim, K. J., & Ashkenazi, A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80212-5 · Cited by 975
Lanotte, M., Martin-Thouvenin, V, Najman, S., Balerini, P., Valensi, F., & Berger, R. (1991) · Blood · doi:10.1182/blood.v77.5.1080.1080 · Cited by 883
Chu, Z.-L., McKinsey, T. A., Liu, L., Gentry, J. J., Malim, M. H., & Ballard, D. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10057 · Cited by 872
Recent Advances in Chemoprevention of Cancer
Hong, W. K., & Sporn, M. B. (1997) · Science · doi:10.1126/science.278.5340.1073 · Cited by 827
Schneider, P., Holler, N., Bodmer, J.-L., Hahne, M., Frei, K., Fontana, A., & Tschopp, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1205 · Cited by 812
Sprick, M. R., Weigand, M. A., Rieser, E., Rauch, C. T., Juo, P., Blenis, J., Krammer, P. H., & Walczak, H. (2000) · Immunity · doi:10.1016/s1074-7613(00)80211-3 · Cited by 794
Zong, W.-X., Edelstein, L. C., Chen, C., Bash, J., & Gelinas, C. (1999) · Genes & Development · doi:10.1101/gad.13.4.382 · Cited by 720
TRAIL receptor-2 signals apoptosis through FADD and caspase-8
Bodmer, J.-L., Holler, N., Reynard, S., Vinciguerra, P., Schneider, P., Juo, P., Blenis, J., & Tschopp, J. (2000) · Nature Cell Biology · doi:10.1038/35008667 · Cited by 649
Wang, J., Zheng, L., Lobito, A., Chan, F. K.-M., Dale, J., Sneller, M., Yao, X., Puck, J. M., Straus, S. E., & Lenardo, M. J. (1999) · Cell · doi:10.1016/s0092-8674(00)80605-4 · Cited by 640
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) Apoptosis Systems
Walczak, H., & Krammer, P. H. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4840 · Cited by 628
Retinoids in cancer chemoprevention
Lotan, R. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.9.8801164 · Cited by 423
Grumont, R. J., Rourke, I. J., & Gerondakis, S. (1999) · Genes & Development · doi:10.1101/gad.13.4.400 · Cited by 403
Lippman, S. M., Parkinson, D. R., Itri, L. M., Weber, R. S., Schantz, S. P., Ota, D. M., Schusterman, M. A., Krakoff, I. H., Gutterman, J. U., & Hong, W. K. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.4.235 · Cited by 393
Chomienne, C., Ballerini, P., Balitrand, N., Daniel, M., Fenaux, P., Castaigne, S., & Degos, L. (1990) · Blood · doi:10.1182/blood.v76.9.1710.1710 · Cited by 375
Self-citationLippman, S. M., Kavanagh, J. J., Paredes-Espinoza, M., Delgadillo-Madrueno, F., Paredes-Casillas, P., Hong, W. K., Holderner, E., & Krakoff, I. H. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.4.241 · Cited by 320
Activation of Retinoid X Receptors Induces Apoptosis in HL-60 Cell Lines
Nagy, L., Thomázy, V. A., Shipley, G. L., Fésüs, L., Lamph, W., Heyman, R. A., Chandraratna, R. A. S., & Davies, P. J. A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.7.3540 · Cited by 241
Tucker, K., Lilly, M., Heck, L. J., & Rado, T. (1987) · Blood · doi:10.1182/blood.v70.2.372.372 · Cited by 227
Wen, J., Ramadevi, N., Nguyen, D., Perkins, C., Worthington, E., & Bhalla, K. (2000) · Blood · doi:10.1182/blood.v96.12.3900 · Cited by 196
Two distinct actions of retinoid-receptor ligands
Chen, J.-Y., Clifford, J., Zusi, C., Starrett, J., Tortolani, D., Ostrowski, J., Reczek, P. R., Chambon, P., & Gronemeyer, H. (1996) · Nature · doi:10.1038/382819a0 · Cited by 194
Self-citationYou, M., Ku, P.-T., Hrdličková, R., & Bose, H. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7328 · Cited by 176
Zamai, L., Secchiero, P., Pierpaoli, S., Bassini, A., Papa, S., Alnemri, E. S., Guidotti, L., Vitale, M., & Zauli, G. (2000) · PubMed · doi:10.1182/blood.v95.12.3716 · Cited by 168
Retinoid receptors in health and disease: co-regulators and the chromatin connection
Minucci, S., & Pelicci, P. G. (1999) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.1999.0303 · Cited by 120
RAR‐independent RXR signaling induces t(15;17) leukemia cell maturation
Benoit, G., Altucci, L., Flexor, M., Ruchaud, S., Lillehaug, J., Raffelsberger, W., Gronemeyer, H., & Lanotte, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.24.7011 · Cited by 111
Self-citationGianni’, M., Ponzanelli, I., Mologni, L., Reichert, U., Rambaldi, A., Terao, M., & Garattini, E. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400673 · Cited by 102
Géhin, M., Vivat, V., Wurtz, J., Losson, R., Chambon, P., Moras, D., & Gronemeyer, H. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80084-2 · Cited by 98
Self-citationSun, S., Yue, P., Hong, W. K., & Lotan, R. (2000) · PubMed · Cited by 97
Sun, S., Yue, P., Chandraratna, R. A. S., Tesfaigzi, Y., Hong, W. K., & Lotan, R. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.3.508 · Cited by 49
The molecular biology of acute promyelocytic leukemia
Slack, J. L., & Gallagher, R. E. (2007) · Springer eBooks · doi:10.1007/978-0-585-38571-6_4 · Cited by 46
Differentiation Therapy for Acute Promyelocytic Leukemia
Fenaux, P., & Degos, L. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371509 · Cited by 44
Bruel, A., Benoit, G., Nay, D. D., Brown, S., & Lanotte, M. (1995) · PubMed · Cited by 44
Pomerantz, J. L., & Baltimore, D. (2000) · Nature · doi:10.1038/35017673 · Cited by 41
Topical treatment of epidemic Kaposi's sarcoma with all-trans-retinoic acid
Bonhomme‐Faivre, L., Fredj, G., Averous, S., Szekely, A. M., Ecstein, E., Trumbic, B., Meyer, P., Lang, J. M., Misset, J. L., & Jasmin, C. (1991) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a057916 · Cited by 39
Moreb, J., & Schweder, M. (1997) · Leukemia · doi:10.1038/sj.leu.2400719 · Cited by 27
Cited by
Targeting death and decoy receptors of the tumour-necrosis factor superfamily
Ashkenazi, A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc821 · Cited by 1,360
Targeting Apoptosis Pathways in Cancer Therapy
Ghobrial, I. M., Witzig, T. E., & Adjei, A. A. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.3.178 · Cited by 1,330
Principles for modulation of the nuclear receptor superfamily
Gronemeyer, H., Gustafsson, J.-Å., & Laudet, V. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1551 · Cited by 1,226
Self-citationReactive oxygen species and cancer paradox: To promote or to suppress?
Galadari, S., Rahman, A., Pallichankandy, S., & Thayyullathil, F. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.004 · Cited by 893
The promise of retinoids to fight against cancer
Altucci, L., & Gronemeyer, H. (2001) · Nature Reviews Cancer · doi:10.1038/35106036 · Cited by 773
Self-citation
Metadata
- Authors
- Altucci, L., Rossin, A., Raffelsberger, W., Reitmair, A., Chomienne, C., & Gronemeyer, H.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Hôpital Saint-Louis (FR)
- Corresponding author
- Gronemeyer, Hinrich
- Venue
- Nature Medicine
- Published
- 2001-06
- Volume
- 7
- Issue
- 6
- Pages
- 680-686
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1551972473
- Cited by
- 340
- References
- 47
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 7 · 2020: 5 · 2019: 8 · 2018: 5 · 2017: 14 · 2016: 6 · 2015: 8 · 2014: 12 · 2013: 9 · 2012: 10
- FWCI
- 11.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- retinoic acid, retinoids, TRAIL, apoptosis, acute promyelocytic leukemia, NB4 cells, retinoic acid receptor alpha, paracrine signaling, retinoic acid resistance, leukemia cell survival
- MeSH terms
- Arsenic Trioxide, Antineoplastic Agents, Arsenicals, Cell Differentiation, Humans, Membrane Glycoproteins, Neoplasm Proteins, Oxides, Proteins, Recombinant Fusion Proteins, Tretinoin, Tumor Cells, Cultured, Tumor Necrosis Factor-alpha, Immunoblotting, Signal Transduction, Leukemia, Promyelocytic, Acute, Oncogene Proteins, Fusion, NF-kappa B, Apoptosis, Receptors, Tumor Necrosis Factor, Coculture Techniques, Paracrine Communication, Caspases, TNF Receptor-Associated Factor 1, Apoptosis Regulatory Proteins, Inhibitor of Apoptosis Proteins, TNF-Related Apoptosis-Inducing Ligand
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.